Answers are grounded in this paper and cite their sources.
HPV-negative CIN2+ or cervical adenocarcinoma is not a concern for the introduction of primary HPV screening in Japan. Primary HPV testing in cervical cancer screening is considered a feasible method that can be used in Japan, although an algorithm suitable for Japan and a national-level management system need to be established.
No takes yet. Share an insight, caveat, or question.
Hideshima et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: